BAIJIN LIFE SCI (01466) released its annual results with a shareholder loss of HK$316,000, a decrease of 95.76% year-on-year.
Baijin Life Sciences (01466) announced its annual performance for the year ending on March 31, 2025, during which the group achieved revenue...
BAIJIN LIFE SCI (01466) announced its annual results for the year ending on March 31, 2025. The Group recorded revenue of HK$136 million during the period, representing a year-on-year increase of 152.54%. The company's attributable loss to owners narrowed by 95.76% to HK$316,000, with a basic loss per share of 0.05 HK cents.
Related Articles
EB SECURITIES: Stablecoins drive the popularity of RMB global payments, third-party payment companies may continue to benefit.
Media expose: Tesla, Inc. (TSLA.US) Siasun Robot & Automation production is far below target, promising to produce 5000 units before the end of the year, but currently only a few hundred units have been produced.
EB SECURITIES: The theme of "anti-internal competition" is expected to help reevaluate the value of copper smelting assets.
EB SECURITIES: Stablecoins drive the popularity of RMB global payments, third-party payment companies may continue to benefit.
Media expose: Tesla, Inc. (TSLA.US) Siasun Robot & Automation production is far below target, promising to produce 5000 units before the end of the year, but currently only a few hundred units have been produced.
EB SECURITIES: The theme of "anti-internal competition" is expected to help reevaluate the value of copper smelting assets.
RECOMMEND
After Eight Consecutive Rate Cuts, the European Central Bank Pauses as Expected; Future Policy Direction Remains Murky
25/07/2025
U.S. President Makes First Official Visit to the Federal Reserve in Nearly 20 Years—What Did Trump and Powell Say?
25/07/2025
New Categories of Air Conditioners in Short Supply, Sales of Ice-Packed Handheld Fans Surge, China’s “Cooling Big Four” Explode in Popularity Across Europe
25/07/2025
